Background Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique
ability to eradicate persister bacilli. The worldwide burden of PZA resistance remains poorly …

Background Interim treatment outcomes at 6-months for multidrug-resistant tuberculosis
(MDR-TB) treatment are among the most basic performance monitoring and key evaluation …

Objective: To determine the prevalence and resistance pattern of multidrug-resistant
tuberculosis. Methods: This cross-sectional study was carried out from January 2010 to June …

Multidrug-resistant tuberculosis (MDR-TB) challenges TB control efforts because of delays in
diagnosis plus its long-term treatment which has toxic effects. Of TB high-incidence …

Background: Tuberculosis (TB) is one of the leading causes of morbidity and mortality in
Pakistan. Assessment of TB treatment outcomes, monitoring and evaluation of its risk factors …

Background: While Pakistan's Programmatic Management of Drug-Resistant Tuberculosis
(PMDT) programme, launched in 2010, initially yielded significant gains in treatment …

Pulmonary tuberculosis (PTB) is a serious public threat throughout the world. PTB and
smoking have a strong correlation. Malnutrition, poverty, addiction, overcrowding, illiteracy …

Background: Tuberculosis is an infectious disease with an estimated 1.45 million deaths
every year. Many patients get infected as a result of ignorance of the risk factors that …

Background: Multi-drug resistant TB (MDR-TB) occurs when the causative agent,
Mycobacterium tuberculosis, becomes resistant to isonazid and rifampin, the two most …

Background: Tuberculosis is highly prevalent in Pakistan. It is a contagious disease and
causes a lot of morbidity and mortality. Its treatment is costly especially for poor countries like …